GlassScriptPhysician profile
Bradley L Spitz
NPI 1063434132
$3,494.63
in general payments reported to CMS, 2019-2025
34 companies · $618 in 2025
The $618 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $445 · 2020: $234 · 2021: $583 · 2022: $784 · 2023: $501 · 2024: $330 · 2025: $618.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,449.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,449.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $774.66 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $686.02 | 2019-2025 | Spiriva Respimat, Ofev, Jascayd |
| Insmed, INC. | $294.06 | 2020-2025 | Arikayce, Brinsupri |
| Astrazeneca Pharmaceuticals LP | $269.43 | 2019-2025 | Breztri, Airsupra, Tezspire |
| Genzyme Corporation | $210.48 | 2021-2025 | |
| Philips North America LLC | $179.11 | 2021-2022 | |
| Grifols USA, LLC | $130.63 | 2024-2025 | Prolastin-C Liquid |
| Takeda Pharmaceuticals U.S.A., INC. | $108.96 | 2021-2025 | Glassia |
| Regeneron Healthcare Solutions, INC. | $95.20 | 2021-2025 | Dupixent |
| Mylan Specialty L.P. | $72.54 | 2022-2024 | Yupelri |
| Mallinckrodt Hospital Products INC. | $69.37 | 2023 | Acthar |
| Paratek Pharmaceuticals, INC. | $66.53 | 2020-2021 | |
| Gilead Sciences, INC. | $48.78 | 2019-2022 | |
| Genentech USA, INC. | $41.49 | 2019-2021 | |
| Viatris Specialty LLC | $39.74 | 2025 | Yupelri |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $37.67 | 2019-2023 | |
| United Therapeutics Corporation | $37.35 | 2019-2021 | |
| Ani Pharmaceuticals, INC. | $27.08 | 2025 | Purified Cortrophin Gel |
| Phadia US INC. | $23.92 | 2024 | Immunocap |
| Verona Pharma, INC. | $23.66 | 2025 | Ohtuvayre |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.45 | 2019 | |
| Allergan, INC. | $21.43 | 2019 | |
| Abbvie INC. | $21.40 | 2023 | Avycaz |
| Melinta Therapeutics, LLC | $21.39 | 2022 | |
| Baxter Healthcare | $20.41 | 2023 | Hillrom - Life 2000 Ventilation System |
| Pulmonx Corporation | $20.00 | 2019 | |
| Shire North American Group INC | $18.66 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $18.04 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $17.50 | 2019 | |
| Pfizer INC. | $17.35 | 2019 | |
| Janssen Pharmaceuticals, INC | $16.29 | 2021 | |
| Circassia INC. | $15.57 | 2019 | |
| Seqirus USA INC | $14.92 | 2021 | |
| Electromed, INC. | $13.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Spitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.